• Explore /
  • Poster
  • / FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial.

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Results of the FFCD 1102 phase II trial.

Abstract Poster

Authors

null

Jean Baptiste Bachet

Pitié Salpétrière Hospital, Paris, France

Jean Baptiste Bachet , Jean-Baptiste Bachet , Olivier Lucidarme , Julien Taïeb , Emilie Maillard , Charles-Briac Levache , Jean-Luc Raoul , Thierry Lecomte , Mohamed Hebbar , Fabien Brocard , Simon Pernot , Gilles Breysacher , Jean-Paul Lagasse , Frédéric Di Fiore , Pierre-Luc Etienne , Olivier Jean Marie Dupuis , Albert Aleba , Come Lepage , Philippe Rougier

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT01674309

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3513)

DOI

10.1200/JCO.2016.34.15_suppl.3513

Abstract #

3513

Poster Bd #

210

Abstract Disclosures

Similar Posters

First Author: Jon Kroll Bjerregaard

First Author: Nai-Jung Chiang

First Author: Changhoon Yoo

First Author: Elisa Giommoni